Interestingly, brassinin induces apoptosis in colon cancer cells with wild-type p53 (HCT116p53+/+) in a dose-dependent manner, while having no such effect on cancer cells lacking functional p53 (null-type). Here, TP53 is linked to malignant colon neoplasm.